Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Bone Marrow Transplant

Retrieve available abstracts of 44 articles:
HTML format



Single Articles


    November 2021
  1. HASHEM H, Rihani R, Shanap MA, Khattab E, et al
    Novel conditioning regimen for upfront haploidentical hematopoietic cell transplantation in children with severe aplastic anemia and donor-specific anti-HLA antibodies.
    Bone Marrow Transplant. 2021 Nov 27. pii: 10.1038/s41409-021-01536.
    PubMed    


  2. ROVO A, Tichelli A
    Cancers after hematopoietic cell transplantation for aplastic anemia-the importance of persistence.
    Bone Marrow Transplant. 2021 Nov 9. pii: 10.1038/s41409-021-01514.
    PubMed    


    October 2021
  3. VO P, Onstad L, Flowers ME, Storb R, et al
    Cancers after HLA-matched related bone marrow transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Oct 16. pii: 10.1038/s41409-021-01498.
    PubMed     Abstract available


  4. DEBUREAUX PE, Kulasekararaj AG, Cacace F, Silva BGP, et al
    Categorizing hematological response to eculizumab in paroxysmal nocturnal hemoglobinuria: a multicenter real-life study.
    Bone Marrow Transplant. 2021;56:2600-2602.
    PubMed    


    September 2021
  5. ABUELGASIM KA, Damlaj M, Bosaeed M, Altamimi S, et al
    Infectious complications in adult sickle cell anemia patients undergoing hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Sep 10. pii: 10.1038/s41409-021-01457.
    PubMed    


    August 2021
  6. DIAZ-DE-HEREDIA C, Bresters D, Faulkner L, Yesilipek A, et al
    Recommendations on hematopoietic stem cell transplantation for patients with Diamond-Blackfan anemia. On behalf of the Pediatric Diseases and Severe Aplastic Anemia Working Parties of the EBMT.
    Bone Marrow Transplant. 2021 Aug 31. pii: 10.1038/s41409-021-01449.
    PubMed     Abstract available


  7. AKDOGAN N, Ersoy-Evans S, Visal Okur F, Kuskonmaz B, et al
    Long-term skin findings in patients with Fanconi anemia after allogeneic hematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2021 Aug 27. pii: 10.1038/s41409-021-01441.
    PubMed    


  8. SINGH AK, Schetzen E, Yadav SK, Lustig EB, et al
    Correction of murine sickle cell disease by allogeneic haematopoietic cell transplantation with anti-3rd party veto cells.
    Bone Marrow Transplant. 2021;56:1818-1827.
    PubMed     Abstract available


    July 2021
  9. BLENNERHASSETT R, Moses JH, Coulits N, Horne A, et al
    Recurrent secondary graft failure likely due to a DRB4 donor-specific antibody in a patient with aplastic anemia and DRB4 null allele.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01402.
    PubMed    


  10. SOCIE G, Peffault de Latour R
    Secondary malignancies after transplantation for aplastic anemia.
    Bone Marrow Transplant. 2021 Jul 7. pii: 10.1038/s41409-021-01400.
    PubMed    


  11. LIU L, Miao M, Chen X, Zhang Y, et al
    Outcomes of severe aplastic anemia patients with infection proceeding with allogeneic hematopoietic stem cell transplantation, versus patients without infection.
    Bone Marrow Transplant. 2021 Jul 3. pii: 10.1038/s41409-021-01398.
    PubMed    


    June 2021
  12. IFTIKHAR R, Chaudhry QN, Mahmood SK, Ghafoor T, et al
    A novel TBI free conditioning protocol for haploidentical transplant in acquired aplastic anemia: (FluCAB-Prime).
    Bone Marrow Transplant. 2021 Jun 25. pii: 10.1038/s41409-021-01385.
    PubMed    


    May 2021
  13. IFTIKHAR R, Ahmad P, de Latour R, Dufour C, et al
    Special issues related to the diagnosis and management of acquired aplastic anemia in countries with restricted resources, a report on behalf of the Eastern Mediterranean blood and marrow transplantation (EMBMT) group and severe aplastic anemia workin
    Bone Marrow Transplant. 2021 May 19. pii: 10.1038/s41409-021-01332.
    PubMed     Abstract available


  14. FRIEDMAN D, Dozor AJ, Milner J, D'Souza M, et al
    Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation.
    Bone Marrow Transplant. 2021 May 6. pii: 10.1038/s41409-021-01298.
    PubMed     Abstract available


    February 2021
  15. MISKIEWICZ-BUJNA J, Miskiewicz-Migon I, Panasiuk A, Kubica-Cielinska A, et al
    Severe and fatal toxicity after hematopoietic stem cell transplantation in GNE defect-associated thrombocytopenia.
    Bone Marrow Transplant. 2021 Feb 26. pii: 10.1038/s41409-021-01235.
    PubMed    


  16. LAI X, Liu L, Zhang Z, Shi L, et al
    Hepatic veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation for thalassemia major: incidence, management, and outcome.
    Bone Marrow Transplant. 2021 Feb 19. pii: 10.1038/s41409-021-01233.
    PubMed     Abstract available


  17. KHARYA G, Bakane A, Agarwal S, Rauthan A, et al
    Pre-transplant myeloid and immune suppression, upfront plerixafor mobilization and post-transplant cyclophosphamide: novel strategy for haploidentical transplant in sickle cell disease.
    Bone Marrow Transplant. 2021;56:492-504.
    PubMed     Abstract available


    December 2020
  18. XU ZL, Huang XJ
    Haploidentical stem cell transplantation for aplastic anemia: the current advances and future challenges.
    Bone Marrow Transplant. 2020 Dec 15. pii: 10.1038/s41409-020-01169.
    PubMed     Abstract available


  19. MURILLO-SANJUAN L, Gonzalez-Vicent M, Argiles Aparicio B, Badell Serra I, et al
    Survival and toxicity outcomes of hematopoietic stem cell transplantation for pediatric patients with Fanconi anemia: a unified multicentric national study from the Spanish Working Group for Bone Marrow Transplantation in Children.
    Bone Marrow Transplant. 2020 Dec 10. pii: 10.1038/s41409-020-01172.
    PubMed     Abstract available


    November 2020
  20. MARCO-AYALA J, Gomez-Segui I, Sanz G, Solves P, et al
    Pure red cell aplasia after major or bidirectional ABO incompatible hematopoietic stem cell transplantation: to treat or not to treat, that is the question.
    Bone Marrow Transplant. 2020 Nov 14. pii: 10.1038/s41409-020-01124.
    PubMed     Abstract available


    October 2020
  21. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Correction: Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Oct 14. pii: 10.1038/s41409-020-01076.
    PubMed     Abstract available


    September 2020
  22. KOYAMAISHI S, Kamio T, Kobayashi A, Sato T, et al
    Reduced-intensity conditioning is effective for hematopoietic stem cell transplantation in young pediatric patients with Diamond-Blackfan anemia.
    Bone Marrow Transplant. 2020 Sep 18. pii: 10.1038/s41409-020-01056.
    PubMed     Abstract available


    July 2020
  23. DEBUREAUX PE, Sicre de Fontbrune F, Bonfim C, Dalle JH, et al
    FLAG-sequential regimen followed by bone marrow transplantation for myelodysplastic syndrome or acute leukemia in patients with Fanconi anemia: a Franco-Brazilian study.
    Bone Marrow Transplant. 2020 Jul 10. pii: 10.1038/s41409-020-0994.
    PubMed    


    May 2020
  24. YOSHIDA N, Takahashi Y, Yabe H, Kobayashi R, et al
    Conditioning regimen for allogeneic bone marrow transplantation in children with acquired bone marrow failure: fludarabine/melphalan vs. fludarabine/cyclophosphamide.
    Bone Marrow Transplant. 2020 May 23. pii: 10.1038/s41409-020-0948.
    PubMed     Abstract available


    April 2020
  25. ELGOHARY G, El Fakih R, de Latour R, Risitano A, et al
    Haploidentical hematopoietic stem cell transplantation in aplastic anemia: a systematic review and meta-analysis of clinical outcome on behalf of the severe aplastic anemia working party of the European group for blood and marrow transplantation (SAAW
    Bone Marrow Transplant. 2020 Apr 28. pii: 10.1038/s41409-020-0897.
    PubMed     Abstract available


  26. CESARO S, Pillon M, Sauer M, Smiers F, et al
    Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Bloo
    Bone Marrow Transplant. 2020 Apr 9. pii: 10.1038/s41409-020-0901.
    PubMed     Abstract available


    March 2020
  27. LIU L, Zhang Y, Jiao W, Zhou H, et al
    Combination of haploidentical haematopoietic stem cell transplantation with an unrelated cord-blood unit in patients with severe aplastic anemia: a report of 146 cases.
    Bone Marrow Transplant. 2020 Mar 26. pii: 10.1038/s41409-020-0874.
    PubMed     Abstract available


  28. CESARO S, Pillon M, Sauer M, Smiers F, et al
    Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow
    Bone Marrow Transplant. 2020 Mar 19. pii: 10.1038/s41409-020-0863.
    PubMed     Abstract available


  29. GLUCKMAN E, Fuente J, Cappelli B, Scigliuolo GM, et al
    The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in Europe.
    Bone Marrow Transplant. 2020 Mar 10. pii: 10.1038/s41409-020-0847.
    PubMed     Abstract available


    February 2020
  30. SHIN SH, Park SS, Yoon JH, Yahng SA, et al
    Comparison of HLA-matched sibling and unrelated donor transplantation in adult patients with acquired severe aplastic anemia.
    Bone Marrow Transplant. 2020 Feb 5. pii: 10.1038/s41409-020-0820.
    PubMed     Abstract available


  31. ALDAWSARI G, Elhaddad A, El Fakih R, Ben Othman T, et al
    Outcome of hematopoietic stem cell transplantation (HCT) from HLA-matched related donor for Fanconi anemia (FA) in adolescents and adults: a retrospective study by Eastern Mediterranean Blood and Marrow Transplantation Group (EMBMT).
    Bone Marrow Transplant. 2020 Feb 5. pii: 10.1038/s41409-020-0809.
    PubMed     Abstract available


    January 2020
  32. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of conditioning with rabbit antithymocyte globulin and rituximab in haploidentical haematopoietic stem cell transplantation in patients with severe aplastic anaemia.
    Bone Marrow Transplant. 2020 Jan 20. pii: 10.1038/s41409-020-0788.
    PubMed    


  33. MA YR, Wang WJ, Cheng YF, Zhang YY, et al
    Impact of ABO incompatibility on outcomes after haploidentical hematopoietic stem cell transplantation for severe aplastic anemia.
    Bone Marrow Transplant. 2020 Jan 13. pii: 10.1038/s41409-020-0779.
    PubMed     Abstract available


    December 2019
  34. PRATA PH, Eikema DJ, Afansyev B, Bosman P, et al
    Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party.
    Bone Marrow Transplant. 2019 Dec 16. pii: 10.1038/s41409-019-0773.
    PubMed     Abstract available


    November 2019
  35. LIU L, Zhang Y, Liu S, Zhou H, et al
    Outcomes of haploidentical haematopoietic stem cell transplantation for paroxysmal nocturnal haemoglobinuria.
    Bone Marrow Transplant. 2019 Nov 19. pii: 10.1038/s41409-019-0751.
    PubMed    


    October 2019
  36. DU S, He W, Yang Y, Gao X, et al
    Unrelated cord blood transplantation for severe aplastic anemia using intensified immunoablative conditioning regimen leading to high engraftment and survival.
    Bone Marrow Transplant. 2019 Oct 29. pii: 10.1038/s41409-019-0736.
    PubMed    


    September 2019
  37. MARWAH P, Soni R, Ramprakash S, Raghuram CP, et al
    The impact of Host vs. Graft mismatches on rejection of haploidentical bone marrow transplants in thalassemia patients using posttransplant cyclophosphamide.
    Bone Marrow Transplant. 2019 Sep 30. pii: 10.1038/s41409-019-0692.
    PubMed    


  38. MILLER PDE, Snowden JA, De Latour RP, Iacobelli S, et al
    Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and
    Bone Marrow Transplant. 2019 Sep 25. pii: 10.1038/s41409-019-0680.
    PubMed     Abstract available


  39. PARK SS, Min GJ, Park S, Lee SE, et al
    Excellent outcomes of hematopoietic stem cell transplantation with total nodal irradiation and antithymocyte globulin conditioning in severe aplastic anemia with advanced age and/or severe comorbidity.
    Bone Marrow Transplant. 2019 Sep 24. pii: 10.1038/s41409-019-0696.
    PubMed    


  40. RAUTENBERG C, Kaivers J, Germing U, Haas R, et al
    Daratumumab for treatment of pure red cell aplasia after allogeneic stem cell transplantation.
    Bone Marrow Transplant. 2019 Sep 3. pii: 10.1038/s41409-019-0664.
    PubMed    


    May 2019
  41. KATOH D, Ochi Y, Hiramoto N, Morita M, et al
    Parvovirus B19 infection in adult patients after allogeneic stem cell transplantation: our experience of five cases and literature review.
    Bone Marrow Transplant. 2019 May 14. pii: 10.1038/s41409-019-0533.
    PubMed    


    March 2019
  42. XU ZL, Xu LP, Zhang YY, Cheng YF, et al
    Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation.
    Bone Marrow Transplant. 2019 Mar 21. pii: 10.1038/s41409-019-0509.
    PubMed     Abstract available


    January 2019
  43. HINO T, Imi T, Hangaishi A, Kamoda Y, et al
    Escape hematopoiesis by donor-derived 6pLOH(+) hematopoietic stem cells in a marrow transplant recipient with late graft failure.
    Bone Marrow Transplant. 2019 Jan 10. pii: 10.1038/s41409-018-0420.
    PubMed    


    May 2018
  44. ASLAM HM, Yousuf S, Kassim A, Iqbal SM, et al
    Hematopoietic stem cell transplantation for adult sickle cell disease in the era of universal donor availibility.
    Bone Marrow Transplant. 2018 May 4. pii: 10.1038/s41409-018-0193.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: